Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Celgene
Memorial Sloan Kettering Cancer Center
Northwestern University
Sarcoma Alliance for Research through Collaboration
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
GE Healthcare
INSYS Therapeutics Inc